𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Parkinson's Disease: The LRRK2-G2019S mutation: opening a novel era in Parkinson's disease genetics

✍ Scribed by Bonifati, Vincenzo


Book ID
110026696
Publisher
Nature Publishing Group
Year
2006
Tongue
English
Weight
56 KB
Volume
14
Category
Article
ISSN
1018-4813

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Genetic and clinical identification of P
✍ Hao Deng; Weidong Le; Yi Guo; Christine B. Hunter; Wenjie Xie; Joseph Jankovic πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 55 KB πŸ‘ 3 views

genes and who were found to be negative. 1 In this group of 122 patients, we identified 5 patients with an FMR1 premutation and in 4 of them a definite diagnosis of fragile Xassociated tremor/ataxia syndrome (FXTAS) could be made, based on the proposed diagnostic criteria for FXTAS. We proposed base

G2019S LRRK2 mutation in familial and sp
✍ Sofya N. Pchelina; Andrei F. Yakimovskii; Olga N. Ivanova; Anton K. Emelianov; A πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 80 KB

## Abstract Among mutations associated with autosomal dominant and sporadic Parkinson's disease (PD) the G2019S substitution in the leucine‐rich repeat kinase 2 (LRRK2) gene is the most frequently identified. To estimate its frequency in Russia, we analyzed 208 patients with PD from the Northwester

MAPK-pathway activity, Lrrk2 G2019S, and
✍ Linda R. White; Mathias Toft; Sylvia N. Kvam; Matthew J. Farrer; Jan O. Aasly πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 238 KB

## Abstract The __6055G>A__ mutation in the __leucine‐rich repeat kinase 2__ (__LRRK2__) gene results in a G2019S substitution in the mixed‐lineage kinase domain of Lrrk2, causing autosomal dominant Parkinson's disease (PD). We hypothesized the mutation alters cellular mitogen‐activated protein kin